ImpiloVest - growing the health and wellness industry in South Africa

ImpiloVest - growing the health and wellness industry in South Africa.

Interview with ImpiloVest Director of Business Development, Paul Nunes.

ImpiloVest was founded to provide a holistic approach to creating value throughout the entire supply chain of health and wellness companies. The company’s business model was founded on a vision to create value from source to shelf by providing quality solutions in health and wellness.

The Director of Business Development, Paul Nunes, shares with Public Sector Leaders how they are making a positive impact on people’s lives, communities, and the environment.

PLEASE DESCRIBE YOUR ROLE AND RESPONSIBILITIES.

I focus on business growth and performance by researching and delivering profitable solutions which will drive sales in all sectors of ImpiloVest. I build and develop a solid corporate brand image and focus on customer retention and future growth opportunities for the business.

IMPILOVEST IS AN INTERESTING NAME – DOES IT REFER TO HEALTH?

It’s a direct translation of Zulu, meaning health, expressing their commitment to revolutionising complementary and alternative medicine in South Africa.

PLEASE UNPACK SOUTH AFRICA’S FIRST OBSERVATIONAL CLINICAL TRIAL ON MEDICAL CANNABIS – WHAT IT MEANS, ITS IMPORTANCE, TIMEFRAME AND IMPACT.

The Cannabis Research Institute of South Africa (CRI) has sponsored a year-long study that examines the effectiveness of medical cannabis as an alternative to opioids for chronic pain management. In addition to demonstrating therapeutic efficacy and pain relief, the objective is to provide credible, reliable, and verifiable data to the relevant authorities to regulate the availability of medicinal cannabis.

Since the cannabis industry has become more customer-centric and customer-facing over the past few years as patients, consumers, and society have become more educated, the industry has seen significant growth. In collaboration with the Releaf Cannabis E-Clinics, a member of the ImpiloVest group, participants of the latest groundbreaking study will have access to their medicinal cannabis through the study. Patients who register for the study will not be charged for their medication as part of the sponsorship.

WHAT IS THE CURRENT STATE OF THE CANNABIS INDUSTRY IN SOUTH AFRICA?

Cannabis or cannabis-derived products are still very much in their infancy and have struggled with numerous challenges in attempts to industrialise the industry. CBD as a cannabinoid was the first to have a scheduled framework attached to it. However, I feel the dosage limits allocated to it are extremely conservative and it has caused efficacy issues at patient level. Complexities around the regulation of recreational cannabis usage have proved to be a challenge for decision-makers. Regulation to legalise commercial activities as regards the production, sale, marketing, and distribution of recreational cannabis in South Africa should as a collective deliver on the needs of key stakeholders within the recreational cannabis value chain. Beyond regulation, there are several other areas of strategic interventions required for the development of the recreational cannabis industry.

WHAT EXCITES YOU ABOUT WHAT YOU DO?

The chance to really make a difference in the health of people and to contribute to communities by creating job opportunities.

WHAT EXCITING PLANS DO YOU HAVE FOR 2023?

We will look to grow the health and wellness industry in South Africa. Health, food and beverage will be the focus of ImpiloVest’s newest division, Afritaste. We would want to have a resolution on the state of the Cannabis market and see how we can assist in its development as a frontrunner in this category.

CONTACT DETAILS

Physical Address: 3 Rose Street, Wellington 7655

Email: info@impilovest.co.za